SOTERA HEALTH COMPANY (SHC) Current Ratio
- Current ratio · latest quarter: Value 2.80×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.80× | Current assets / current liabilities. $646.46M ÷ $231.24M ≈ 2.80× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 646.46M USD | Assets, Current |
| Current obligations | 231.24M USD | Liabilities, Current |
| Cash and equivalents | 356.72M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 150.54M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 56.37M USD | Inventory, Net |
| Payables | 101.02M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 13.92M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $646.46M | $231.24M | $356.72M | (m) | $150.54M | $56.37M | $101.02M | $13.92M | 2.80× |
| 2026-03-31 | $585.97M | $207.80M | $314.15M | (m) | $137.26M | $57.49M | $76.69M | $13.98M | 2.82× |
| 2025-12-31 | $613.41M | $249.58M | $344.62M | (m) | $139.33M | $54.38M | $77.96M | $13.97M | 2.46× |
| 2025-09-30 | $577.82M | $242.40M | $299.19M | (m) | $142.39M | $49.87M | $61.39M | $13.96M | 2.38× |
| 2025-06-30 | $608.17M | $246.32M | $332.44M | (m) | $136.56M | $59.95M | $63.66M | $14.82M | 2.47× |
| 2025-03-31 | $554.99M | $225.99M | $304.39M | (m) | $128.07M | $61.05M | $70.11M | $14.81M | 2.46× |
| 2024-12-31 | $526.04M | $191.00M | $277.24M | (m) | $140.33M | $49.16M | $55.10M | $14.80M | 2.75× |
| 2024-09-30 | $563.61M | $195.54M | $306.74M | (m) | $130.12M | $53.65M | $70.75M | $14.79M | 2.88× |
| 2024-06-30 | $497.68M | $169.63M | $246.08M | (m) | $123.66M | $57.87M | $64.49M | $11.09M | 2.93× |
| 2024-03-31 | $487.18M | $152.34M | $261.13M | (m) | $111.07M | $51.34M | $61.58M | $4.81M | 3.20× |
| 2023-12-31 | $557.24M | $230.65M | $296.41M | (m) | $147.70M | $48.32M | $71.04M | $4.80M | 2.42× |
| 2023-09-30 | $519.65M | $200.59M | $244.96M | (m) | $118.40M | $37.92M | $57.13M | $5.24M | 2.59× |
| 2023-06-30 | $546.69M | $200.33M | $262.70M | (m) | $117.31M | $42.10M | $55.58M | $5.22M | 2.73× |
| 2023-03-31 | $923.80M | $600.15M | $647.95M | (m) | $109.16M | $46.74M | $61.94M | $4.03M | 1.54× |
| 2022-12-31 | $645.01M | $791.57M | $395.21M | (m) | $118.48M | $37.15M | $74.14M | $197.12M | 0.81× |
| 2022-09-30 | $420.73M | $140.03M | $163.97M | (m) | $111.61M | $37.15M | $60.73M | $0.00 | 3.00× |
| 2022-06-30 | $398.68M | $142.02M | $139.56M | (m) | $119.85M | $39.65M | $65.27M | (m) | 2.81× |
| 2022-03-31 | $371.56M | $143.85M | $121.44M | (m) | $114.76M | $45.70M | $55.22M | (m) | 2.58× |
| 2021-12-31 | $345.96M | $161.16M | $106.92M | (m) | $108.18M | $54.29M | $72.87M | $0.00 | 2.15× |
| 2021-09-30 | $337.31M | $133.61M | $114.91M | (m) | $96.09M | $37.50M | $51.81M | (m) | 2.52× |
| 2021-06-30 | $401.11M | $148.79M | $156.22M | (m) | $118.41M | $35.72M | $63.15M | (m) | 2.70× |
| 2021-03-31 | $328.37M | $138.02M | $108.01M | (m) | $96.39M | $33.38M | $57.17M | (m) | 2.38× |
| 2020-12-31 | $315.01M | $140.60M | $102.45M | (m) | $91.73M | $34.09M | $52.40M | $0.00 | 2.24× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |